INTRODUCTION: Automated assisted peritoneal dialysis (AAPD) has been shown to be successful as renal replacement therapy for elderly and physically incapable end-stage renal disease (ESRD) patients. In early 2003, a pioneer AAPD program was initiated at GAMEN Renal Clinic in Rio de Janeiro, Brazil. ♢ OBJECTIVE: We evaluated the results of an AAPD program offered as an option to elderly ESRD patients with physical or cognitive debilities or as last resort to patients with vascular access failure or hemodynamic instability during hemodialysis. ♢ METHODS: A cohort of 30 consecutive patients started AAPD from January 2003 to March 2008 and was followed to July 2009. Demographics, clinical and laboratory parameters, causes of death, and patient and technique survival were analyzed. ♢ RESULTS: Median age of the patients was 72 years (range: 47 - 93 years), with 60% being older than 65. The Davies score was greater than 2 in 73% of patients, and the Karnofsky index was less than 70 in 40%. The overall peritonitis rate was 1 episode in 37 patient-months. The total duration of AAPD ranged from 3 to 72 months. Patient survival was 80% at 12 months, 60% at 24 months, and 23.3% at 48 months. The most common cause of death was cardiovascular problems (70%). ♢ CONCLUSIONS: In this clinical observational study, AAPD fulfilled its expected role, offering an opportune, reliable, and effective homecare alternative for ESRD patients with no other renal replacement therapy options.
INTRODUCTION: Automated assisted peritoneal dialysis (AAPD) has been shown to be successful as renal replacement therapy for elderly and physically incapable end-stage renal disease (ESRD) patients. In early 2003, a pioneer AAPD program was initiated at GAMEN Renal Clinic in Rio de Janeiro, Brazil. ♢ OBJECTIVE: We evaluated the results of an AAPD program offered as an option to elderly ESRDpatients with physical or cognitive debilities or as last resort to patients with vascular access failure or hemodynamic instability during hemodialysis. ♢ METHODS: A cohort of 30 consecutive patients started AAPD from January 2003 to March 2008 and was followed to July 2009. Demographics, clinical and laboratory parameters, causes of death, and patient and technique survival were analyzed. ♢ RESULTS: Median age of the patients was 72 years (range: 47 - 93 years), with 60% being older than 65. The Davies score was greater than 2 in 73% of patients, and the Karnofsky index was less than 70 in 40%. The overall peritonitis rate was 1 episode in 37 patient-months. The total duration of AAPD ranged from 3 to 72 months. Patient survival was 80% at 12 months, 60% at 24 months, and 23.3% at 48 months. The most common cause of death was cardiovascular problems (70%). ♢ CONCLUSIONS: In this clinical observational study, AAPD fulfilled its expected role, offering an opportune, reliable, and effective homecare alternative for ESRDpatients with no other renal replacement therapy options.
Authors: M von Faber; A Bootsma-van der Wiel; E van Exel; J Gussekloo; A M Lagaay; E van Dongen; D L Knook; S van der Geest; R G Westendorp Journal: Arch Intern Med Date: 2001 Dec 10-24
Authors: N B Dimkovic; S Prakash; J Roscoe; J Brissenden; P Tam; J Bargman; S I Vas; D G Oreopoulos Journal: Nephrol Dial Transplant Date: 2001-10 Impact factor: 5.992
Authors: B Issad; D Benevent; M Allouache; P Y Durand; D Aguilera; R Milongo; P Dubot; S Lavaud; J Gary Journal: Perit Dial Int Date: 1996 Impact factor: 1.756
Authors: Kitty J Jager; Johanna C Korevaar; Friedo W Dekker; Raymond T Krediet; Elisabeth W Boeschoten Journal: Am J Kidney Dis Date: 2004-05 Impact factor: 8.860
Authors: Osasuyi U Iyasere; Edwina A Brown; Lina Johansson; Les Huson; Joanna Smee; Alexander P Maxwell; Ken Farrington; Andrew Davenport Journal: Clin J Am Soc Nephrol Date: 2015-12-28 Impact factor: 8.237
Authors: Jorge I Fonseca-Correa; Janine F Farragher; George Tomlinson; Matthew J Oliver; Arsh Jain; Susan Flanagan; Kathleen Koyle; Sarbjit V Jassal Journal: Kidney360 Date: 2021-01-12
Authors: Matthew J Oliver; Ahmed A Al-Jaishi; Stephanie N Dixon; Jeffrey Perl; Arsh K Jain; Susan D Lavoie; Danielle M Nash; J Michael Paterson; Charmaine E Lok; Robert R Quinn Journal: Clin J Am Soc Nephrol Date: 2016-07-27 Impact factor: 8.237
Authors: Caroline E Sloan; Cynthia J Coffman; Linda L Sanders; Matthew L Maciejewski; Shoou-Yih D Lee; Richard A Hirth; Virginia Wang Journal: Clin J Am Soc Nephrol Date: 2019-11-21 Impact factor: 8.237